What is the Historic and Current Scenario of the Microarray Scanners Market?
The microarray scanners market has seen considerable growth due to a variety of factors.
•The market size of microarray scanners has seen robust growth in the past years. There is an anticipated expansion from $0.94 billion in 2024 to $1.01 billion in 2025, which suggests a compound annual growth rate (CAGR) of 7.1%.
This remarkable increase during the historical period can be linked to factors such as the rise in genomic research, expansion of the pharmaceutical industry, advancements in academic and research institutions, diagnostic applications, and high-throughput screening.
What are the Forecasted Growth and Key Factors of the Microarray Scanners Market?
The microarray scanners market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for microarray scanners is projected to witness robust growth over the coming years, reaching a value of $1.38 billion in 2029 with a compound annual growth rate (CAGR) of 8.1%.
This anticipated growth during the forecast period could be due to an increased emphasis on pharmacogenomics, rising demand for biobanking, a heightened focus on infectious disease research, an escalating need for diagnostic laboratories, and expanding application fields of microarrays. Notable trends during the predicted period include a concentration on cancer research, technological advancements, and strategic alliances.
What Main Forces Are Fueling Expansion In The Microarray Scanners Market?
An increase in chronic diseases is foreseen to fuel the expansion of the market for microarray scanners. Chronic diseases, which persist for three months or longer and may worsen over time, are of particular interest. Microarray scanners can examine gene expression patterns, affording researchers the opportunity to delve into the molecular mechanisms that influence chronic diseases and identify potential biomarkers for diagnosis, future predictions, and treatments. For example, the National Center for Biotechnology Information (NCBI), a U.S. National Library of Medicine, anticipates that the global population of chronic disease patients will reach 142.66 million by 2050 as per the report in January 2023. Consequently, the escalating prevalence of chronic diseases is a pivotal factor driving the boom in the microarray scanner market.
What Are The Primary Segments In The Global Microarray Scanners Market?
The microarray scanners market covered in this report is segmented –
1) By Product Type: Fluorescence Microarray Scanners, Charge-Coupled Devices Microarray Scanners, Colorimetric Microarray Scanners, Other Product Types
2) By Technology: Slide-based, Gel-based
3) By Application: Gene Expression, Drug Discovery, Other Applications
4) By End User: Hospitals, Diagnostic Laboratories, Pharmaceutical And Biotechnology Companies, Academic And Research Institutes
Subsegments:
1) By Fluorescence Microarray Scanners: Laser Scanners, Multispectral Scanners
2) By Charge-Coupled Devices (CCD) Microarray Scanners: Standard CCD Scanners, High-Resolution CCD Scanners
3) By Colorimetric Microarray Scanners: Slide Scanners, Digital Colorimetric Scanners
4) By Other Product Types: Hybrid Scanners, Custom Or Specialized Microarray Scanners
Pre-Book The Microarray Scanners Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Key Trends Are Driving Changes In The Microarray Scanners Market?
The emergence of product innovations is an integral trend proliferating in the microarray scanners industry. Predominant companies in the microarray scanners industry are introducing pioneering products to sustain their presence in the industry. For instance, in June 2023, MARGenomics, a company based in Spain, unveiled the Applied Biosystems GeneChip 3000 Dx v2, a progressive microarray platform, marking a noteworthy advancement in the realm of microarray technology. The platform holds the distinction of being the first in Europe and the United States to acquire regulatory approval for diagnostic usages, alluding to its likely influence on clinical diagnostics and research. Its high-resolution genomic data provision capability seems set to reinforce personalized medicine strategies in an array of therapeutic sectors.
Who Are the Key Players in the Microarray Scanners Market?
Major companies operating in the microarray scanners market include:
• F. Hoffmann-La Roche AG
• Thermo Fisher Scientific Inc.
• GE Healthcare Life Sciences
• Hitachi High-Tech Corporation
• Innopsys Inc.
• PerkinElmer Inc.
• VWR International LLC
• Illumina Inc.
• Bio-Rad Laboratories Inc.
• Agilent Technologies Inc.
• Tecan Group AG
• Huron Technologies International Inc.
• Miltenyi Biotec B.V. & Co. KG
• GVS S.p.A.
• Luminex Corporation
• Molecular Devices LLC
• CapitalBio Technology Inc.
• Berthold Technologies GmbH & Co. KG
• RayBiotech Inc.
• Scienion AG
• Oxford Gene Technology IP Limited
• Applied Microarrays Inc.
• Arrayit Corporation
• Meridian Bioscience Inc.
• Montreal Biotech Inc.
What Is The Most Dominant Region In The Microarray Scanners Market?
North America was the largest region in the microarray scanners market in 2024. The regions covered in the microarray scanners market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
